York Faulkner, an IP partner from Finnegan, Henderson, Farabow, Garrett & Dunner, has joined Quinn Emanuel Urquhart & Sullivan in Tokyo.
Neil Di Spirito has left Ballard Spahr to join Epstein Becker Green as a member of the firm’s healthcare and life sciences practice.
Medical technology company Biocompatibles UK last week withdrew its oppositions to two trademarks applied for by Pfizer, four months after settlement negotiations.
The UK government today published four documents about how Brexit will impact the operations and regulatory status of life sciences companies.
German scientists claim to have developed a way of identifying counterfeit breast implants by using DNA sequences from tomatoes.
Morgan Lewis & Bockius has boosted its IP litigation team with the addition of seven partners from McDermott Will & Emery who have experience in the life sciences and technology industries.
Vanessa Yen has joined King & Spalding's trial and global disputes practice group as a partner after leaving Paul Hastings.
Dusa Pharmaceuticals, a subsidiary of India-based generic drug maker Sun Pharma, has accused dermatology-focused company Biofrontera of misappropriating trade secrets.
A medical technology trade association has warned that the US tariffs recently implemented in response to Chinese IP theft may hinder patient access to life-saving technologies.
Novartis has created a platform called Nerve Live that will tap into its “huge data pool” in order to aid drug development.